DVA | DaVitaNYSEHealthcareCommon stock golden cross and death cross projections, cross tests and history

$182.17
-$3.57 (-1.92%)

DaVita (DVA) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.

The 50 SMA has sat above the 200 on the daily since Mar 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the weekly, price sits above the 50 and the 200; on the 4-hour it is between the two.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
above both $182.17 vs 50 $181.75 / 200 $177.80
Projection
No cross projected
Test
No active test
Last cross
Golden cross 13 Mar 2026 ยท projected 28 bars out

Weekly as of 30 Oct 16:00 ET

Price
above both $187.50 vs 50 $167.30 / 200 $135.02
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 11 Mar 2024 ยท projected 13 bars out

4-hour as of 3 Nov 16:00 ET

Price
between the two $182.17 vs 50 $181.91 / 200 $197.86
Projection
No cross projected
Test
No active test
Last cross
Death cross 31 Aug 2026 ยท projected 30 bars out

Cross history

28
crosses on record since 2017
14 golden14 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
31 Aug 2026Death4-hour30 bars outNot tested
13 Mar 2026Golden steepdaily28 bars outNot tested
18 Feb 2026Golden4-hour28 bars outNot tested
6 Aug 2025Death4-hour8 bars outโ€”
30 Jul 2025Golden4-hour21 bars outโ€”

About DVA

ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$104M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandlarge

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.